| 臺大學術典藏 |
2022-09-16T03:41:35Z |
Human leucocyte antigen-Cw6 as a predictor for clinical response to ustekinumab, an interleukin-12/23 blocker, in Chinese patients with psoriasis: A retrospective analysis
|
Chiu H.-Y.; Wang T.-S.; Chan C.-C.; Cheng Y.-P.; SUNG-JAN LIN; Tsai T.-F. |
| 臺大學術典藏 |
2022-09-16T03:41:34Z |
Risk factor analysis for the immunogenicity of adalimumab associated with decreased clinical response in Chinese patients with psoriasis
|
Chiu H.-Y.; Wang T.-S.; Chan C.-C.; SUNG-JAN LIN; Tsai T.-F. |
| 臺大學術典藏 |
2022-09-16T03:41:32Z |
Correlation of IL36RN mutation with different clinical features of pustular psoriasis in Chinese patients
|
Wang T.-S.; Chiu H.-Y.; Hong J.-B.; Chan C.-C.; SUNG-JAN LIN; Tsai T.-F. |
| 臺大學術典藏 |
2022-01-11T06:49:48Z |
The effectiveness and safety of adalimumab in the treatment of non-reimbursed patients with mild-to-moderate psoriasis
|
HSIEN-YI CHIU; Wang T.-S.; Chang C.-Y.; Tsai T.-F. |
| 臺大學術典藏 |
2022-01-11T06:49:45Z |
Etanercept use for psoriasis in Taiwan: A case series study
|
HSIEN-YI CHIU; Wang T.-S.; Cho Y.-T.; Tsai T.-F. |
| 臺大學術典藏 |
2022-01-11T06:49:43Z |
Human leucocyte antigen-Cw6 as a predictor for clinical response to ustekinumab, an interleukin-12/23 blocker, in Chinese patients with psoriasis: A retrospective analysis
|
HSIEN-YI CHIU; Wang T.-S.; Chan C.-C.; Cheng Y.-P.; Lin S.-J.; Tsai T.-F. |
| 臺大學術典藏 |
2022-01-11T06:49:43Z |
Correlation of thiopurine methyltransferase and inosine triphosphate pyrophosphatase polymorphisms and adverse effects induced by azathioprine treatment in Taiwanese dermatology patients
|
Wang T.-S.; HSIEN-YI CHIU; Wu L.S.-H.; Chu C.-Y.; Tsai T.-F. |
| 臺大學術典藏 |
2022-01-11T06:49:42Z |
Development of lichen striatus in a psoriasis patient treated with adalimumab
|
Lin I.-C.; Wang T.-S.; HSIEN-YI CHIU; Tsai T.-F. |
| 臺大學術典藏 |
2022-01-11T06:49:42Z |
Practical experience of ustekinumab in patients with moderate-to-severe psoriasis who had inadequate therapeutic response to previous tumor necrosis factor blockers
|
Wang T.-C.; HSIEN-YI CHIU; Wang T.-S.; Tsai T.-F. |
| 臺大學術典藏 |
2022-01-11T06:49:42Z |
Risk factor analysis for the immunogenicity of adalimumab associated with decreased clinical response in Chinese patients with psoriasis
|
HSIEN-YI CHIU; Wang T.-S.; Chan C.-C.; Lin S.-J.; Tsai T.-F. |
| 臺大學術典藏 |
2022-01-11T06:49:40Z |
Correlation of IL36RN mutation with different clinical features of pustular psoriasis in Chinese patients
|
Wang T.-S.; HSIEN-YI CHIU; Hong J.-B.; Chan C.-C.; Lin S.-J.; Tsai T.-F. |
| 臺大學術典藏 |
2022-01-11T06:49:39Z |
Concomitant sleep disorders significantly increase the risk of cardiovascular disease in patients with psoriasis
|
HSIEN-YI CHIU; Hsieh C.-F.; Chiang Y.-T.; Tsai Y.-W.; Huang W.-F.; Li C.-Y.; Wang T.-S.; Tsai T.-F. |
| 臺大學術典藏 |
2022-01-11T06:49:36Z |
Secukinumab in psoriasis patients with prior ustekinumab treatment: Results of a single-center experience
|
Wang T.-S.; Chan C.-C.; HSIEN-YI CHIU; Tsai T.-F. |
| 臺大學術典藏 |
2022-01-11T06:49:34Z |
Serial QuantiFERON-TB Gold testing in patients with psoriasis treated with ustekinumab
|
Hsiao C.-Y.; HSIEN-YI CHIU; Wang T.-S.; Tsai T.-F. |
| 臺大學術典藏 |
2022-01-11T06:49:33Z |
Safety profile of secukinumab in treatment of patients with psoriasis and concurrent hepatitis B or C: A multicentric prospective cohort study
|
HSIEN-YI CHIU; Hui R.C.-Y.; Huang Y.-H.; Huang R.-Y.; Chen K.-L.; Tsai Y.-C.; Lai P.-J.; Wang T.-S.; Tsai T.-F. |
| 臺大學術典藏 |
2022-01-11T06:49:31Z |
Psoriasis in Taiwan: From epidemiology to new treatments
|
HSIEN-YI CHIU; Wang T.-S.; Chen P.-H.; Hsu S.-H.; Tsai Y.-C.; Tsai T.-F. |
| 臺大學術典藏 |
2022-01-11T06:49:30Z |
Human leukocyte antigen and demographic characteristics in Chinese patients with active peripheral type psoriatic arthritis who had inadequate response to conventional disease-modifying antirheumatic drugs in a single dermatologic clinic
|
Sin C.-Z.; Wang T.-S.; HSIEN-YI CHIU; Tsai T.-F. |
| 臺大學術典藏 |
2022-01-11T06:49:25Z |
Recommendations for psoriatic arthritis management: A joint position paper of the Taiwan Rheumatology Association and the Taiwanese Association for Psoriasis and Skin Immunology
|
Tsai T.-F.; Hsieh T.-Y.; Chi C.-C.; Chou C.-T.; Hsieh L.-F.; Chen H.-H.; Hui R.C.-Y.; Lee C.-H.; Liu C.-H.; Liu H.-C.; Yeo K.-J.; Chen C.-H.; Chen H.-A.; Chen Y.-C.; Chen Y.-J.; HSIEN-YI CHIU; Ho J.-C.; Huang Y.-H.; Lai P.-J.; Lee W.-R.; Liao H.-T.; Lin S.-H.; Tseng J.-C.; Wang T.-S.; Wu N.-L.; Yang D.-H.; Tsai W.-C.; Wei J.C.-C.; Taiwan Rheumatology Association (TRA); the Taiwanese Association for Psoriasis; Skin Immunology (TAPSI) |
| 臺大學術典藏 |
2022-01-11T06:49:24Z |
Predictors of hepatitis B and C virus reactivation in patients with psoriasis treated with biologic agents: a 9-year multicenter cohort study
|
HSIEN-YI CHIU; Chiu Y.-M.; Chang Liao N.-F.; Chi C.-C.; Tsai T.-F.; Hsieh C.-Y.; Hsieh T.-Y.; Lai K.-L.; Chiu T.-M.; Wu N.-L.; Hui R.C.-Y.; Lee C.-N.; Wang T.-S.; Chen P.-H.; Yang C.-C.; Huang Y.-H. |
| 臺大學術典藏 |
2021-10-28T07:11:19Z |
Correlation of clinical diagnosis of dactylitis by the dermatologist and ultrasonographic diagnosis by the rheumatologist in patients with psoriasis arthritis: Experience of a single clinic
|
Lo Y.; Wang T.-S.; Li K.-J.; TSEN-FANG TSAI |
| 臺大學術典藏 |
2021-10-28T07:11:18Z |
Recommendations for psoriatic arthritis management: A joint position paper of the Taiwan Rheumatology Association and the Taiwanese Association for Psoriasis and Skin Immunology
|
TSEN-FANG TSAI; Hsieh T.-Y.; Chi C.-C.; Chou C.-T.; Hsieh L.-F.; Chen H.-H.; Hui R.C.-Y.; Lee C.-H.; Liu C.-H.; Liu H.-C.; Yeo K.-J.; Chen C.-H.; Chen H.-A.; Chen Y.-C.; Chen Y.-J.; Chiu H.-Y.; Ho J.-C.; Huang Y.-H.; Lai P.-J.; Lee W.-R.; Liao H.-T.; Lin S.-H.; Tseng J.-C.; Wang T.-S.; Wu N.-L.; Yang D.-H.; Tsai W.-C.; Wei J.C.-C.; Taiwan Rheumatology Association (TRA); the Taiwanese Association for Psoriasis; Skin Immunology (TAPSI) |
| 臺大學術典藏 |
2021-10-28T07:11:16Z |
Predictors of hepatitis B and C virus reactivation in patients with psoriasis treated with biologic agents: a 9-year multicenter cohort study
|
Chiu H.-Y.; Chiu Y.-M.; Chang Liao N.-F.; Chi C.-C.; TSEN-FANG TSAI; Hsieh C.-Y.; Hsieh T.-Y.; Lai K.-L.; Chiu T.-M.; Wu N.-L.; Hui R.C.-Y.; Lee C.-N.; Wang T.-S.; Chen P.-H.; Yang C.-C.; Huang Y.-H. |
| 臺大學術典藏 |
2021-09-04T06:11:07Z |
Pegylated IFN-α suppresses hepatitis C virus by promoting the DAPK-mTOR pathway
|
Liu W.-L.; Yang H.-C.; Hsu C.-S.; Wang C.-C.; Wang T.-S.; JIA-HORNG KAO; Chen D.-S. |
| 臺大學術典藏 |
2021-09-04T05:16:40Z |
Resistance-associated substitution and ledipasvir/sofosbuvir therapy in Mongolian chronic hepatitis C patients
|
Hsu S.-J.; Enkhzaya S.; Lin Y.-Y.; Tseng T.-C.; Khosbayar T.; Tsai C.-H.; Wang T.-S.; Enkhtuya D.; Ivshinkhorol D.; Naranzul N.; Jargalsaikhan B.; Amarsanaa J.; Baatarkhuu O.; JIA-HORNG KAO |
| 國立成功大學 |
2021 |
Predictors of hepatitis B and C virus reactivation in patients with psoriasis treated with biologic agents: a 9-year multicenter cohort study
|
Chiu, H.-Y.;Chiu, Y.-M.;Chang, Liao N.-F.;Chi, Chi C.-C.;Tsai, Tsai T.-F.;Hsieh, C.-Y.;Hsieh, T.-Y.;Lai, K.-L.;Chiu, T.-M.;Wu, N.-L.;Hui, R.C.-Y.;Lee, C.-N.;Wang, T.-S.;Chen, P.-H.;Yang, C.-C.;Huang, Y.-H. |
